Analysis of real-world data on postremission therapy for acute myeloid leukemia with intermediate risk cytogenetics in first complete remission

VYDRA, J.^G; ŠÁLEK, C.; SCHWARZ, J.; ŽÁK, P.; NOVÁK, J.; PETEČUKOVÁ, V.; PECHERKOVÁ, P.; MAYER, J.; CETKOVSKÝ, P.; RÁČIL, Z. Analysis of real-world data on postremission therapy for acute myeloid leukemia with intermediate risk cytogenetics in first complete remission. Clinical lymphoma, myeloma & leukemia. 2018, vol. 18, no. 2, s. 106-113. ISSN 2152-2650. SJR: 1.059, rok: 2018; Cite Score: 3.600, rok: 2018; IF: 2.274, rok: 2018.